*Some Market data delayed by 15 mins.

Praxis Precision Medicines, Inc. Common Stock

Symbol: PRAX (NASDAQ)
40.81 ▲ (1.95%) 0.780

Company Description:
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

Key Stats
  • Today's Open: $40.61
  • Today's High: $42.52
  • Today's Low: $38.895
  • Today's Volume: 293.05K
  • Yesterday Close: $40.03
  • Yesterday High: $41.08
  • Yesterday Low: $38
  • Yesterday Volume: 720.38K
  • Last Min Volume: 7.76K
  • Last Min High: $40.81
  • Last Min Low: $40.81
  • Last Min VWAP: $40.81
Company Profile
  • Name: Praxis Precision Medicines, Inc. Common Stock
  • Website: https://www.praxismedicines.com
  • Listed Date: 2020-10-16
  • Location: BOSTON, MA
  • Market Status: Active
  • CIK Number: 0001689548
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $857.77M
  • Round Lot: 100
  • Outstanding Shares: 21.05M
  • Asset Type: CS
RECENT FILINGS FOR PRAX
Filing Date Filing Type Format
2025-09-05 8-K View
2025-09-05 424B5 View
2025-09-02 SCHEDULE 13G/A View
2025-08-19 3 View
2025-08-14 SCHEDULE 13G/A View
2025-08-14 SCHEDULE 13G/A View
2025-08-14 SCHEDULE 13G/A View
2025-08-12 SCHEDULE 13G/A View
2025-08-05 SCHEDULE 13G/A View
2025-08-04 8-K View
2025-08-04 10-Q View
2025-07-22 SCHEDULE 13G View
2025-07-17 8-K View
2025-06-27 4 View
2025-06-27 4 View
2025-06-27 4 View
2025-06-27 4 View
2025-06-27 4 View
2025-06-27 4 View
2025-06-27 8-K View
Latest News on PRAX

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.